Table 1 Summary of the protocols and proteomics dataset of PRA and PRB both progesterone-independent and dependent.

From: Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer

Treatment

Protocol 1

Protocol 2

Protocol 3

Data

P4 independent replicate 1

Forward SILAC PRA: L PRB: H Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 independent replicate 2

Forward SILAC PRA: L PRB: H Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 independent replicate 3

Forward SILAC PRA: L PRB: H Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 independent replicate 1

Reverse SILAC PRA: H PRB: L Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 independent replicate 2

Reverse SILAC PRA: H PRB: L Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 independent replicate 3

Reverse SILAC PRA: H PRB: L Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 dependent replicate 1

Forward SILAC PRA: L PRB: H Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 dependent replicate 2

Forward SILAC PRA: L PRB: H Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 dependent replicate 3

Forward SILAC PRA: L PRB: H Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 dependent replicate 1

Reverse SILAC PRA: H PRB: L Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 dependent replicate 2

Reverse SILAC PRA: H PRB: L Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

P4 dependent replicate 3

Reverse SILAC PRA: H PRB: L Control: M

Co-Immunoprecipitation

Nano LC-MS/MS

PXD023920

  1. L: Light labeling, M: Medium labeling, and H: Heavy labeling.